Lewis L. Truex

451 total citations
18 papers, 389 citations indexed

About

Lewis L. Truex is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Lewis L. Truex has authored 18 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in Lewis L. Truex's work include Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). Lewis L. Truex is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Neurotransmitter Receptor Influence on Behavior (3 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). Lewis L. Truex collaborates with scholars based in United States, Canada and Jordan. Lewis L. Truex's co-authors include Barry D. Sawyer, Winston S. Marshall, J H Fleisch, Martin Schmidt, Andrew S. Fix, Mark M. Foreman, Michael Schmidt, David F. Wozniak, J. Philip Miller and Melanie L. McEwen and has published in prestigious journals such as Cancer Research, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Lewis L. Truex

18 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis L. Truex United States 11 184 171 98 49 38 18 389
Anne M. Morin United States 13 256 1.4× 226 1.3× 135 1.4× 23 0.5× 63 1.7× 20 516
Jean-Christophe Delumeau France 14 285 1.5× 307 1.8× 94 1.0× 29 0.6× 92 2.4× 20 800
Nataliya Svichar United States 12 245 1.3× 394 2.3× 128 1.3× 40 0.8× 30 0.8× 14 533
F. Aporti Italy 9 122 0.7× 181 1.1× 77 0.8× 17 0.3× 16 0.4× 17 344
Kiyotaka Katsuta Japan 10 117 0.6× 110 0.6× 47 0.5× 64 1.3× 97 2.6× 18 368
A. Flamier France 7 396 2.2× 352 2.1× 76 0.8× 62 1.3× 56 1.5× 8 630
Yasuhito Naito Japan 15 165 0.9× 361 2.1× 194 2.0× 31 0.6× 30 0.8× 22 649
Jen Barnes United Kingdom 11 161 0.9× 218 1.3× 170 1.7× 73 1.5× 51 1.3× 15 501
W. G. Ohlsson United States 11 142 0.8× 201 1.2× 73 0.7× 26 0.5× 23 0.6× 13 393
M Dóda Hungary 10 154 0.8× 158 0.9× 71 0.7× 67 1.4× 30 0.8× 39 377

Countries citing papers authored by Lewis L. Truex

Since Specialization
Citations

This map shows the geographic impact of Lewis L. Truex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis L. Truex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis L. Truex more than expected).

Fields of papers citing papers by Lewis L. Truex

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis L. Truex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis L. Truex. The network helps show where Lewis L. Truex may publish in the future.

Co-authorship network of co-authors of Lewis L. Truex

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis L. Truex. A scholar is included among the top collaborators of Lewis L. Truex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis L. Truex. Lewis L. Truex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Uluer, Ahmet, et al.. (2024). P119 Improving cystic fibrosis care in Jordan through quality improvement initiatives in collaboration with U.S. cystic fibrosis centers. Journal of Cystic Fibrosis. 23. S122–S122. 1 indexed citations
2.
Young, Jamie, et al.. (2004). Toxicity of single-dose oral gemcitibine in mice.. Cancer Research. 64. 486–487. 1 indexed citations
3.
Truex, Lewis L., et al.. (1997). 12-Month Chronic Toxicity Study of LY275585 (Human Insulin Analog) Administered Subcutaneously to Fischer 344 Rats. International Journal of Toxicology. 16(6). 639–657. 10 indexed citations
4.
Fix, Andrew S., David F. Wozniak, Lewis L. Truex, et al.. (1995). Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Research. 696(1-2). 194–204. 78 indexed citations
5.
6.
7.
Schaus, John M., et al.. (1990). Aporphines as antagonists of dopamine D-1 receptors. Journal of Medicinal Chemistry. 33(2). 600–607. 25 indexed citations
8.
Riggs, Robert M., David E. Nichols, Mark M. Foreman, & Lewis L. Truex. (1987). Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonists. Journal of Medicinal Chemistry. 30(10). 1887–1891. 18 indexed citations
9.
Riggs, Robert M., Ann T. McKenzie, Stephen R. Byrn, et al.. (1987). Effect of .beta.-alkyl substitution on D-1 dopamine agonist activity: absolute configuration of .beta.-methyldopamine. Journal of Medicinal Chemistry. 30(10). 1914–1918. 13 indexed citations
10.
Riggs, Robert M., David E. Nichols, Mark M. Foreman, et al.. (1987). Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3c]pyridine analog. Journal of Medicinal Chemistry. 30(8). 1454–1458. 22 indexed citations
11.
Schmidt, Martin, Barry D. Sawyer, Lewis L. Truex, Winston S. Marshall, & J H Fleisch. (1985). LY83583: an agent that lowers intracellular levels of cyclic guanosine 3',5'-monophosphate.. Journal of Pharmacology and Experimental Therapeutics. 232(3). 764–769. 125 indexed citations
12.
Schwartz, Joan P., Bernardino Ghetti, Lewis L. Truex, & Michael Schmidt. (1982). Increase of a nerve growth factor‐like protein in the cerebellum of PCD mutant mice. Journal of Neuroscience Research. 8(2-3). 205–211. 11 indexed citations
13.
Ghetti, Bernardino, Lewis L. Truex, Barry D. Sawyer, Samuel J. Strada, & Michael Schmidt. (1981). Exaggerated cyclic AMP accumulation and glial cell reaction in the cerebellum during Purkinje cell degeneration in pcd mutant mice. Journal of Neuroscience Research. 6(6). 789–801. 33 indexed citations
14.
Truex, Lewis L. & M. Schmidt. (1980). 3H-amphetamine concentrations in the brains of young and aged rats: Implications for assessment of drug effects in aged animals. Neurobiology of Aging. 1(1). 93–95. 14 indexed citations
15.
Schmidt, Michael, Lewis L. Truex, Bernardino Ghetti, & Aryeh Routtenberg. (1980). Cyclic AMP‐Dependent Protein Kinase Activity in Human Brain Across Age. Journal of Neurochemistry. 35(1). 261–265. 7 indexed citations
16.
Schmidt, Michael, Lewis L. Truex, Richard G. Conway, & Aryeh Routtenberg. (1979). CYCLIC AMP‐DEPENDENT PROTEIN KINASE ACTIVITY AND SYNAPTOSOMAL PROTEIN PHOSPHORYLATION IN THE BRAINS OF AGED RATS. Journal of Neurochemistry. 32(2). 335–344. 10 indexed citations
17.
Schmidt, J. Michael, et al.. (1979). Ethanol inhibition of antigen-induced histamine release from guinea pig lung: Correlation with intracellular levels of cyclic nucleotides. Life Sciences. 24(25). 2321–2331. 1 indexed citations
18.
Schmidt, Michael, et al.. (1978). CYCLIC NUCLEOTIDES and PROTEIN KINASE ACTIVITY IN THE RAT BRAIN POSTMORTEM. Journal of Neurochemistry. 31(2). 427–431. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Morin Breakdown of academic impact, for papers by Jean-Christophe Delumeau Breakdown of academic impact, for papers by Nataliya Svichar Breakdown of academic impact, for papers by F. Aporti Breakdown of academic impact, for papers by Kiyotaka Katsuta Breakdown of academic impact, for papers by A. Flamier Breakdown of academic impact, for papers by Yasuhito Naito Breakdown of academic impact, for papers by Jen Barnes Breakdown of academic impact, for papers by W. G. Ohlsson Breakdown of academic impact, for papers by M Dóda
Rankless by CCL
2026